| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-14 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-14 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-12 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-11 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-11 |